Back to School: How biopharma can reboot drug development. Access exclusive analysis here
CEPH (West Chester, Penn.) presented animal data showing that daily subcutaneous dosing with IGF-1 (1mg/kg) concomitant
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury